AKT1 and leukemia: Interestingly, the translocation t(9;22) encoding for the BCR-ABL fusion protein expressed in SupB15 cells was shown to induce autocrine IGF-1 signaling in leukemia, which may confer clinical resistance due to higher IGF-1R signaling and constitutive P-Akt activity.